A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems in an industrywide shift to streamline drug development. More than 650 companies use Veeva Development Cloud applications today, and more than 250 are leveraging multiple Veeva Vault applications across functional areas to enable and connect drug development and manufacturing teams.

“Managing drug development across multiple siloed systems is no longer sustainable to move with speed and efficiency,” says Klaas Boone, Senior Director of Business Information Systems at Argenx. “We’re passionate about making what we do better, and using Veeva Development Cloud applications to connect our teams will help drive innovation from clinical trials through regulatory submission and manufacturing.”

Veeva Development Cloud brings together suites of unified applications for clinical, regulatory, quality, and safety on a single cloud platform, eliminating organizational silos. More than 350 companies are accelerating trial execution with Vault Clinical applications, more than 250 are streamlining regulatory processes with Vault RIM, more than 350 are unifying quality management with Vault Quality, and more than 35 are improving pharmacovigilance with Vault Safety. Pharmacovigilance, also known as drug safety, is the pharmacological science relating to the assessment, monitoring, and prevention of adverse effects with pharmaceuticals.“

"We're unifying clinical and regulatory to facilitate information sharing across teams,” says Jim Clark, IT Veeva Center of Excellence Leader at Spark Therapeutics. “Having Veeva Vault suites in place, all connected, in the cloud, is critically important to ensure continued development success.”

Vault Connections in Veeva Development Cloud drive cross-functional business processes across the product lifecycle. For example, Connections enable companies to bring together clinical operations and regulatory for faster submissions; quality and regulatory for simplified change control and variation management; and clinical data and operations for real-time visibility into patient enrollment.

“Bringing together clinical operations and regulatory submissions enables real-time availability of protocols, investigational brochures, and other key study documents that help us remain compliant,” says Dee DeOliveira, Global Director of Regulatory Operations at Cerevel Therapeutics. “We’re thrilled with how Vault Connections enable collaboration, and we’ve just scratched the surface on the processes that can be enhanced or automated to speed development.”

Veeva Development Cloud is enabling customers to improve collaboration across teams and speed the delivery of treatments to patients, according to Jim Reilly, Vice President of Veeva Vault Research and Development. “We’re dedicated to bringing innovations to market that help the industry accelerate drug development.”

Veeva Systems, which is headquartered at Hacienda, is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 975 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

For more information about Veeva Systems, please visit www.veeva.com.